Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylscopolamine versus placebo infusion for renal colic refractory to oral NSAIDs
NL-OMON29114Recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Renal colic and Lithiasis comparing Butylscopolamine infusion with Placebo saline infusion (2 arms). Primary endpoint: Amount of escape medication during 24 hours. Started Jan 2018; status: recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
Renal colicLithiasis
Beyond the preview
Go deeper on NL-OMON29114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29114.